Shockwave Medical Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Doug Godshall
Chief executive officer
US$9.5m
Total compensation
| CEO salary percentage | 7.6% |
| CEO tenure | 7yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.3yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors
Apr 06
Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?
Mar 24Shockwave Medical: Opening Arteries, Delivering Returns
Feb 28Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Feb 18There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital
Feb 06Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)
Jan 24Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio
Jan 09Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?
Dec 27Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?
Dec 13What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?
Nov 17Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?
Oct 19Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation
Oct 06Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet
Sep 20Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?
Sep 07When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?
Jul 10We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger
Jun 26We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease
Jun 13Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?
May 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$163m |
| Dec 31 2023 | US$9m | US$716k | US$147m |
| Sep 30 2023 | n/a | n/a | US$244m |
| Jun 30 2023 | n/a | n/a | US$244m |
| Mar 31 2023 | n/a | n/a | US$241m |
| Dec 31 2022 | US$8m | US$644k | US$216m |
| Sep 30 2022 | n/a | n/a | US$88m |
| Jun 30 2022 | n/a | n/a | US$55m |
| Mar 31 2022 | n/a | n/a | US$29m |
| Dec 31 2021 | US$7m | US$575k | -US$9m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$53m |
| Mar 31 2021 | n/a | n/a | -US$71m |
| Dec 31 2020 | US$5m | US$546k | -US$66m |
| Sep 30 2020 | n/a | n/a | -US$65m |
| Jun 30 2020 | n/a | n/a | -US$65m |
| Mar 31 2020 | n/a | n/a | -US$57m |
| Dec 31 2019 | US$2m | US$477k | -US$51m |
| Sep 30 2019 | n/a | n/a | -US$48m |
| Jun 30 2019 | n/a | n/a | -US$45m |
| Mar 31 2019 | n/a | n/a | -US$44m |
| Dec 31 2018 | US$511k | US$376k | -US$41m |
Compensation vs Market: Doug's total compensation ($USD9.48M) is below average for companies of similar size in the US market ($USD13.65M).
Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.
CEO
Doug Godshall (58 yo)
7yrs
Tenure
US$9,478,729
Compensation
Mr. Douglas E. Godshall, also known as Doug, M.B.A., is Director of Saluda Medical, Inc. He serves as Chair of the Board of Galvanize Therapeutics, Inc. since September 2022. He has been the Chief Executiv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7yrs | US$9.48m | 0.29% $ 36.5m | |
| President & Chief Commercial Officer | 1.9yrs | US$3.23m | 0.15% $ 18.8m | |
| Founder and Senior Advisor | 15.3yrs | no data | no data | |
| Co-Founder and Technical Advisor | 15.3yrs | no data | no data | |
| Chief Financial Officer | less than a year | no data | 0.053% $ 6.7m | |
| Senior Vice President of Global Operations | less than a year | no data | no data | |
| Chief Accounting Officer | 2.3yrs | no data | 0.13% $ 16.9m | |
| Vice President of Investor Relations | less than a year | no data | no data | |
| General Counsel & Secretary | 4.9yrs | no data | no data | |
| Senior Vice President of Marketing & Market Access | 7.8yrs | no data | no data | |
| Vice President of Sales | less than a year | no data | no data | |
| Senior Director of Human Resources | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
52yo
Average Age
Experienced Management: SWAV's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7yrs | US$9.48m | 0.29% $ 36.5m | |
| Independent Director | 10.8yrs | US$277.06k | no data | |
| Independent Director | 13yrs | US$273.62k | 0.76% $ 95.7m | |
| Independent Chairman of the Board | 5.3yrs | US$333.62k | 0.012% $ 1.5m | |
| Independent Director | 5.3yrs | US$297.37k | 0.011% $ 1.4m | |
| Independent Director | 3.2yrs | US$278.62k | 0.0052% $ 651.0k | |
| Independent Director | 3.8yrs | US$289.87k | 0.0096% $ 1.2m | |
| Independent Director | less than a year | US$508.05k | no data | |
| Independent Director | 10.9yrs | US$278.62k | 0.010% $ 1.3m |
5.3yrs
Average Tenure
57yo
Average Age
Experienced Board: SWAV's board of directors are considered experienced (5.3 years average tenure).